Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition Inv. presentation Quarterly results Appointed director
|
APPLIED GENETIC TECHNOLOGIES CORP (AGTC)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/14/2023 |
SC 13G/A
| Beryl Capital Management LLC reports a 0% stake in Applied Genetic Technologies Corporation |
12/12/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
12/08/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
12/07/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
12/07/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
12/07/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
12/01/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
12/01/2022 |
4
| Robinson James A. Jr. (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Disposed/sold 25,000 options to buy
@ $2.17, valued at
$54.3k
|
|
12/01/2022 |
4
| VANLENT ANNE (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Disposed/sold 16,000 options to buy
@ $15.13, valued at
$242.1k
Disposed/sold 8,000 options to buy
@ $7.75, valued at
$62k
Disposed/sold 10,000 options to buy
@ $4.25, valued at
$42.5k
Disposed/sold 10,000 options to buy
@ $6.9, valued at
$69k
Disposed/sold 10,000 options to buy
@ $3.02, valued at
$30.2k
Disposed/sold 12,000 options to buy
@ $4.72, valued at
$56.6k
Disposed/sold 14,000 options to buy
@ $2.17, valued at
$30.4k
|
|
12/01/2022 |
4
| Rosen James (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Unknown transaction of 1,000 shares
@ $0 Disposed/sold 9,375 options to buy
@ $12, valued at
$112.5k
Disposed/sold 4,688 options to buy
@ $20.83, valued at
$97.7k
Disposed/sold 6,200 options to buy
@ $16.06, valued at
$99.6k
Disposed/sold 8,000 options to buy
@ $7.75, valued at
$62k
Disposed/sold 10,000 options to buy
@ $4.25, valued at
$42.5k
Disposed/sold 10,000 options to buy
@ $6.9, valued at
$69k
Disposed/sold 10,000 options to buy
@ $3.02, valued at
$30.2k
Disposed/sold 12,000 options to buy
@ $4.72, valued at
$56.6k
Disposed/sold 14,000 options to buy
@ $2.17, valued at
$30.4k
|
|
12/01/2022 |
4
| Aliski William (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Unknown transaction of 8,500 shares
@ $0 Disposed/sold 25,000 options to buy
@ $4.4, valued at
$110k
Disposed/sold 10,000 options to buy
@ $6.9, valued at
$69k
Disposed/sold 10,000 options to buy
@ $3.02, valued at
$30.2k
Disposed/sold 12,000 options to buy
@ $4.72, valued at
$56.6k
Disposed/sold 14,000 options to buy
@ $2.17, valued at
$30.4k
|
|
12/01/2022 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Unknown transaction of 25,672 shares
@ $0 Unknown transaction of 1,800 shares
@ $0 Disposed/sold 9,375 options to buy
@ $12, valued at
$112.5k
Disposed/sold 4,688 options to buy
@ $20.83, valued at
$97.7k
Disposed/sold 6,200 options to buy
@ $16.06, valued at
$99.6k
Disposed/sold 8,000 options to buy
@ $7.75, valued at
$62k
Disposed/sold 10,000 options to buy
@ $4.25, valued at
$42.5k
Disposed/sold 10,000 options to buy
@ $6.9, valued at
$69k
Disposed/sold 10,000 options to buy
@ $3.02, valued at
$30.2k
Disposed/sold 12,000 options to buy
@ $4.72, valued at
$56.6k
Disposed/sold 14,000 options to buy
@ $2.17, valued at
$30.4k
|
|
12/01/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/01/2022 |
4
| Hashad Yehia (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Disposed/sold 25,000 options to buy
@ $3.42, valued at
$85.5k
Disposed/sold 14,000 options to buy
@ $2.17, valued at
$30.4k
|
|
12/01/2022 |
4
| Koenig Scott (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Unknown transaction of 34,246 shares
@ $0 Disposed/sold 14,285 options to buy
@ $4.9, valued at
$70k
Disposed/sold 9,375 options to buy
@ $12, valued at
$112.5k
Disposed/sold 4,688 options to buy
@ $20.83, valued at
$97.7k
Disposed/sold 6,200 options to buy
@ $16.06, valued at
$99.6k
Disposed/sold 8,000 options to buy
@ $7.75, valued at
$62k
Disposed/sold 10,000 options to buy
@ $4.25, valued at
$42.5k
Disposed/sold 10,000 options to buy
@ $6.9, valued at
$69k
Disposed/sold 10,000 options to buy
@ $3.02, valued at
$30.2k
Disposed/sold 12,000 options to buy
@ $4.72, valued at
$56.6k
Disposed/sold 14,000 options to buy
@ $2.17, valued at
$30.4k
|
|
12/01/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/01/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/01/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/01/2022 |
4
| Reynolds Gerald Anthony (Chief Accounting Officer) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Unknown transaction of 8,506 shares
@ $0 Disposed/sold 42,500 shares
@ $0 Disposed/sold 50,000 options to buy
@ $3.28, valued at
$164k
Disposed/sold 30,000 options to buy
@ $5.5, valued at
$165k
Disposed/sold 34,500 options to buy
@ $3.7, valued at
$127.7k
|
|
12/01/2022 |
4
| Scaria Abraham (Chief Scientific Officer) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Disposed/sold 220,000 options to buy
@ $1.98, valued at
$435.6k
Disposed/sold 124,500 options to buy
@ $0.4, valued at
$49.8k
|
|
12/01/2022 |
4
| Potter Stephen W (Chief Business Officer) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Unknown transaction of 47,133 shares
@ $0 Disposed/sold 8,750 shares
@ $0 Disposed/sold 131,049 options to buy
@ $24.62, valued at
$3.2M
Disposed/sold 51,000 options to buy
@ $18.48, valued at
$942.5k
Disposed/sold 50,000 options to buy
@ $15.57, valued at
$778.5k
Disposed/sold 50,000 options to buy
@ $4.9, valued at
$245k
Disposed/sold 85,000 options to buy
@ $4.25, valued at
$361.3k
Disposed/sold 52,000 options to buy
@ $3, valued at
$156k
Disposed/sold 50,000 options to buy
@ $5.5, valued at
$275k
Disposed/sold 60,000 options to buy
@ $3.74, valued at
$224.4k
Disposed/sold 133,100 options to buy
@ $0.4, valued at
$53.2k
|
|
12/01/2022 |
4
| DOyley-Gay Hope (General Counsel) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Disposed/sold 180,000 options to buy
@ $2.02, valued at
$363.6k
Disposed/sold 147,900 options to buy
@ $0.4, valued at
$59.2k
|
|
12/01/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/01/2022 |
4
| Schneider Susan (Chief Medical Officer) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Disposed/sold 180,000 options to buy
@ $2.76, valued at
$496.8k
Disposed/sold 142,300 options to buy
@ $0.4, valued at
$56.9k
|
|
12/01/2022 |
4
| Lieber Jonathan I (CFO) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Disposed/sold 202,000 options to buy
@ $3.3, valued at
$666.6k
Disposed/sold 154,700 options to buy
@ $0.4, valued at
$61.9k
|
|
12/01/2022 |
4
| Washer Susan B. (President and CEO) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Unknown transaction of 143,021 shares
@ $0 Disposed/sold 140,000 options to buy
@ $4.9, valued at
$686k
Disposed/sold 99,156 options to buy
@ $14.08, valued at
$1.4M
Disposed/sold 55,780 options to buy
@ $16, valued at
$892.5k
Disposed/sold 80,000 options to buy
@ $18.48, valued at
$1.5M
Disposed/sold 80,000 options to buy
@ $15.57, valued at
$1.2M
Disposed/sold 100,000 options to buy
@ $4.9, valued at
$490k
Disposed/sold 100,000 options to buy
@ $4.25, valued at
$425k
Disposed/sold 100,000 options to buy
@ $3, valued at
$300k
Disposed/sold 169,000 options to buy
@ $5.5, valued at
$929.5k
Disposed/sold 275,000 options to buy
@ $3.74, valued at
$1M
|
|
12/01/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
12/01/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
12/01/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
12/01/2022 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
12/01/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
12/01/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
11/29/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
11/29/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
|
|
|